Dengue Vaccines Market

  • ID: 3631626
  • Report
  • Region: Global
  • 80 Pages
  • ABCC Research
1 of 4
After the launch of the first dengue vaccine, the market is expected to experience rapid growth. High unmet need in the market for safe and efficacious dengue vaccines expected drive rapid uptake of pipeline agents. Many companies are aggressive in building their pipeline and bringing their product to market. This opens up opportunities for many companies to plan to in-license or co-market with the developers especially in the high demand markets like India, Thailand, Mexico etc. This report helps understand the opportunities in the market along with the competitive scenario, patient population and pipeline analysis of companies working on the Dengue vaccine.

Research Methodology:

The research is based on both primary and secondary research.

Primary interviews are conducted among the following respondents:

- Physicians at the respective countries
- Companies developing the vaccine
- Consultants / Experts / KOLs
- Other stake holders such as Regulatory bodies, Industry associations etc.

Markets Considered:

Following Five key markets are considered in the report:

- India
- Thailand
- Singapore
- Brazil
- Mexico
Note: Product cover images may vary from those shown
2 of 4
1. Introduction

2. Disease Overview
2.a Symptoms
2.b Pathophysiology
2.c Etiology

3. Epidemiology
3.1 Risk Factors
3.2 Incidence and Geographic Distribution
3.3 Disease Patterns
3.4 Different Serotypes
3.5 Forecast (2009-2023)
3.1.1 Reported Cases
3.1.1.1 Gender wise Reported Cases
3.1.1.2 Age group wise Reported Reported Cases
3.1.1.3 Age-Standardized Incidence of Reported cases
3.1.2 Forecast

4. Current Surveillance, Diagnosis, Prevention, Control Measures, Immunization and Infrastructure
4.1 Overview
4.2 India
4.3 Thailand
4.4 Singapore
4.5 Brazil
4.6 Mexico

5. Opportunity Assessment

6. Unmet Needs in the Market

7. Research and Development Strategies

8. Partnerships, Acquisitions, and Licensing Agreements

9. Clinical Trial

10. Pipeline Analysis

11. Clinical Benchmarking of Key Pipeline Vaccines

12. Commercial Benchmarking of Key Pipeline Vaccines

13. Competitive Assessment

14. Top-Line Five-Year Forecast (2016-2020)
14.1 India
14.2 Thailand
14.3 Singapore
14.4 Brazil
14.5 Mexico

15. Executive Summary

16. Annexure
16.1 Research Methodology
16.2 Forecast Methodology and Assumptions
16.3 Bibliography
16.4 Abbreviations

List of Charts, Graphs and Tables

- Chart: Sales of Dengue Vaccines, 2015
- Chart: Competitive assessment of Dengue vaccines pipeline
- Chart: Gender wise distribution of reported cases of Dengue in India, Thailand, Singapore, Brazil & Mexico
- Chart: Reported cases of Dengue in India, Thailand, Singapore, Brazil & Mexico
- Chart: Forecast of Dengue vaccine market in India, Thailand, Singapore, Brazil & Mexico
- Graph: Incidence rate of Dengue in India, Thailand, Singapore, Brazil and Mexico
- Graph: Reported cases of Dengue
- Graph: Age-group wise distribution of reported cases of Dengue in India, Thailand, Singapore, Brazil & Mexico
- Table: Case Definitions of Dengue as per WHO
- Table: Risk factors for severe Dengue
- Table: Disease pattern of Dengue fever
- Table: Different serotypes of Dengue
- Table: Reported cases of Dengue
- Table: Gender wise distribution of reported cases of Dengue in India, Thailand, Singapore, Brazil & Mexico
- Table: Age-group wise distribution of reported cases of Dengue in India, Thailand, Singapore, Brazil & Mexico
- Table: National Immunization Program schedule, India
- Table: Immunization schedule, Thailand
- Table: Immunization schedule, Singapore
- Table: Immunization schedule, Brazil
- Table: Immunization schedule, Mexico
- Table: Agreements in Dengue vaccine market
- Table: Clinical trial designs of selected vaccines
- Table: Clinical development pipeline, Dengue vaccines
- Table: Product profile of vaccine under clinical development, Vaccine-1
- Table: Product efficacy profile of vaccine under clinical development, Vaccine-1
- Table: Product safety profile of vaccine under clinical development, Vaccine-1
- Table: Product SWOT analysis of vaccine under clinical development, Vaccine-1
- Table: Product profile of vaccine under clinical development, Vaccine-2
- Table: Product efficacy profile of vaccine under clinical development, Vaccine-2
- Table: Product SWOT analysis of vaccine under clinical development, Vaccine-2
- Table: Product profile of vaccine under clinical development, Vaccine-3
- Table: Product efficacy profile of vaccine under clinical development, Vaccine-3
- Table: Product safety profile of vaccine under clinical development, Vaccine-3
- Table: Product SWOT analysis of vaccine under clinical development, Vaccine-3
- Table: Product profile of vaccine under clinical development, Vaccine-4
- Table: Product SWOT analysis of vaccine under clinical development, Vaccine-4
- Table: Product profile of vaccine under clinical development, Vaccine-5
- Table: Product efficacy profile of vaccine under clinical development, Vaccine-5
- Table: Product SWOT analysis of vaccine under clinical development, Vaccine-5
- Table: Vaccines in pre-clinical development
- Table: Clinical benchmarking of pipeline vaccines
- Table: Commercial benchmarking of pipeline vaccines
- Table: Forecast of Dengue vaccine market in India, Thailand, Singapore, Brazil & Mexico
- Table: Events that may impact and their level of impact on Dengue vaccines market
- Table: Key figures in India, Thailand, Singapore, Brazil and Mexico
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll